Indeed, from 70 patients with CRC considered to be at high risk of LS, 46 displayed unambiguous MSS status with the pentaplex panel and no aberrant HSP110 was detected in 45 of these 46 tumors (98%). This evidence concerns the gene HSPH1 and colorectal carcinoma.